Pfizer’s Oral COVID-19 Pill Paxlovid Tops Merck’s Molnupiravir

 
• By Joseph Haas
  
COVID-19 red cells on white
Pfizer's oral antiviral sharply reduces hospitalization/mortality risk in trial
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip